Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination


Kilic E. K. , Bulut C., SÖNMEZER M. Ç. , Ozel O., Hatipoglu C. A. , Ertem G. T. , ...Daha Fazla

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.13, ss.886-891, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 13 Konu: 10
  • Basım Tarihi: 2019
  • Doi Numarası: 10.3855/jidc.10859
  • Dergi Adı: JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
  • Sayfa Sayıları: ss.886-891

Özet

Introduction: Linezolid is a synthetic antimicrobial agent with a broad spectrum of activity against virtually all Gram-positive bacteria. Although linezolid is generally well tolerated, the prolonged use of linezolid can lead to myelosuppression, including neutropenia, thrombocytopenia, and anemia. The aim of this study was investigating the risk factors for thrombocytopenia in patients who received linezolid therapy.